MetLife Investment Management’s CyrusOne Inc Common Stock CONE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-61,503
| Closed | -$5.52M | – | 2792 |
|
|
2021
Q4 | $5.52M | Buy |
61,503
+1,923
| +3% | +$163K | 0.05% | 359 |
|
|
2021
Q3 | $4.61M | Sell |
59,580
-1,648
| -3% | -$124K | 0.04% | 407 |
|
|
2021
Q2 | $4.38M | Sell |
61,228
-995
| -2% | -$72.5K | 0.04% | 456 |
|
|
2021
Q1 | $4.21M | Sell |
62,223
-3,674
| -6% | -$255K | 0.04% | 477 |
|
|
2020
Q4 | $4.82M | Sell |
65,897
-1,017
| -2% | -$73.8K | 0.05% | 368 |
|
|
2020
Q3 | $4.69M | Sell |
66,914
-1,498
| -2% | -$117K | 0.05% | 337 |
|
|
2020
Q2 | $4.98M | Buy |
68,412
+3,434
| +5% | +$245K | 0.06% | 308 |
|
|
2020
Q1 | $4.01M | Hold |
64,978
| – | – | 0.05% | 321 |
|
|
2019
Q4 | $4.25M | Sell |
64,978
-857
| -1% | -$58.8K | 0.04% | 429 |
|
|
2019
Q3 | $5.21M | Sell |
65,835
-1,215
| -2% | -$81.1K | 0.06% | 316 |
|
|
2019
Q2 | $3.87M | Buy |
67,050
+1,064
| +2% | +$62.4K | 0.04% | 477 |
|
|
2019
Q1 | $3.46M | Buy |
65,986
+1,454
| +2% | +$76.1K | 0.04% | 536 |
|
|
2018
Q4 | $3.41M | Buy |
64,532
+492
| +0.8% | +$28.1K | 0.04% | 461 |
|
|
2018
Q3 | $4.06M | Buy |
64,040
+1,747
| +3% | +$113K | 0.04% | 467 |
|
|
2018
Q2 | $3.63M | Buy |
62,293
+2,305
| +4% | +$125K | 0.04% | 488 |
|
|
2018
Q1 | $3.07M | Buy |
59,988
+2,227
| +4% | +$119K | 0.04% | 600 |
|
|
2017
Q4 | $3.44M | Buy |
+57,761
| New | +$3.5M | 0.04% | 557 |
|
Other funds holding CONE
MetLife Investment Management's CONE Position: Q1 2022 in Review
MetLife Investment Management sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 61,503 shares — an estimated $5.52M sold.
MetLife Investment Management first reported a position in CONE in Q4 2017 and held it in 17 quarters. The position peaked at $5.52M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.
- MetLife Investment Management reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
- MetLife Investment Management sold 61,503 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $5.52M.
- MetLife Investment Management first reported a position in CyrusOne Inc Common Stock in Q4 2017 and held it in 17 quarters.
- MetLife Investment Management's CyrusOne Inc Common Stock position peaked at $5.52M in Q4 2021.
- 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.